The Mammalian Arg/N-End Rule Pathway: Substrates, Functions, and Mechanisms
哺乳动物 Arg/N 端规则途径:底物、功能和机制
基本信息
- 批准号:8601698
- 负责人:
- 金额:$ 53.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-02-11 至 2017-02-28
- 项目状态:已结题
- 来源:
- 关键词:26S proteasomeAddressAminopeptidaseApoptosisBRCA1 geneBiologicalBiological ProcessBiologyCalpainCaspaseDefectDown-RegulationDoxycyclineElastasesEukaryotaGlutamineGrantHalf-LifeHealthHumanIndividualInfectionKnock-in MouseLaboratoriesLeadLengthLifeLigaseMalignant NeoplasmsMammalian CellMediatingMedicalModificationMusMutant Strains MiceN-terminalNerve DegenerationPathway interactionsPeptide HydrolasesPhysiologicalPlayProbabilityProgress ReportsProtein FragmentProtein PrecursorsProteinase 3ProteinsProteolysisPublicationsPuromycinRIPK1 geneRoleSignal TransductionSyndromeSystemTargeted ResearchTransferaseUbiquitinarginyllysineaspartylglutamatedeamidationhuman diseasein vivoinsightleucyl-phenylalaninemulticatalytic endopeptidase complexmutantprotein degradationpublic health relevancerecogninssecretasetryptophyltyrosineubiquitin ligase
项目摘要
DESCRIPTION (provided by applicant): Regulated proteolysis by the ubiquitin-proteasome system (ubiquitin system) plays essential roles in a multitude of biological processes, and has major ramifications for human health. Our studies of the ubiquitin system and the N-end rule pathway over the last three decades were made possible, to a large extent, by the present grant (DK039520), currently in its 27th year of support. This renewal application is about the N-end rule pathway of protein degradation. In eukaryotes, this pathway is a specific part of the ubiquitin system. The N-end rule relates the in vivo half-life of a protein to the identity of its -terminal residue. The N-end rule pathway of protein degradation consists of two distinct branches, the Ac/N-end rule pathway and the Arg/N-end rule pathway. The Ac/N-end rule pathway was discovered by our laboratory in 2010. It recognizes proteins with N-terminally acetylated residues. The Arg/N-end rule pathway, which targets specific unacetylated N-terminal residues, was discovered by our laboratory in 1986. This pathway continues to be a fount of biological insights and remains a major focus of our studies. The present (DK039520) renewal application is about the Arg/N-end rule pathway and the identification (as well as detailed studies) of new physiological Arg/N-rule substrates. Therefore the previous title of the DK039520 grant ("Ubiquitin Ligases, Mechanisms and Functions of the N-End Rule Pathway") was modified as follows in the present renewal application, to reflect its current emphasis: "The Mammalian Arg/N-End Rule Pathway: Substrates, Functions, and Mechanisms". The projects of this renewal application include functional and mechanistic studies of specific physiological substrates of the mammalian (mouse) Arg/N-end rule pathway, and the identification of new mammalian Arg/N-end rule substrates, including those that act as proapoptotic protein fragments, i.e., fragments whose formation during apoptosis (a specific kind of programmed cell death) increases the probability of apoptosis.
描述(由申请人提供):由泛素-蛋白酶体系统(泛素系统)调节的蛋白水解在许多生物过程中起重要作用,并对人类健康产生重大影响。我们在过去三十年中对遍在蛋白系统和N端规则途径的研究在很大程度上得益于目前的资助(DK 039520),目前已进入第27年的支持。本次更新申请是关于蛋白质降解的N端规则途径。在真核生物中,该途径是泛素系统的特定部分。N-末端规则将蛋白质的体内半衰期与其N-末端残基的身份联系起来。蛋白质降解的N-末端规则途径由两个不同的分支组成,Ac/N-末端规则途径和Arg/N-末端规则途径。Ac/N-end规则途径是我们实验室在2010年发现的。它识别具有N-末端乙酰化残基的蛋白质。Arg/N-end rule pathway是本实验室于1986年发现的一种以特定的非乙酰化N-末端残基为靶点的分子。这一途径仍然是生物学见解的源泉,仍然是我们研究的主要焦点。目前(DK 039520)的更新申请是关于Arg/N-末端规则途径和新的生理Arg/N-规则底物的鉴定(以及详细研究)。因此,DK 039520授权的先前标题(“N-末端规则途径的泛素连接酶、机制和功能”)在本更新申请中修改如下,以反映其当前的重点:“哺乳动物Arg/N-末端规则途径:底物、功能和机制”。本次更新申请的项目包括哺乳动物(小鼠)Arg/N-末端规则途径的特定生理底物的功能和机制研究,以及新的哺乳动物Arg/N-末端规则底物的鉴定,包括作为促凋亡蛋白片段的那些,即,在细胞凋亡(一种特殊的程序性细胞死亡)过程中形成的片段增加了细胞凋亡的可能性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ALEXANDER J VARSHAVSKY其他文献
ALEXANDER J VARSHAVSKY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ALEXANDER J VARSHAVSKY', 18)}}的其他基金
Ubiquitin Ligases, Mechanisms and Functions of the N-End Rule Pathway
N 端规则通路的泛素连接、机制和功能
- 批准号:
7996378 - 财政年份:2009
- 资助金额:
$ 53.89万 - 项目类别:
Split Proteins As Boolean Circuits and Drugs of a New Kind
将蛋白质拆分为布尔电路和新型药物
- 批准号:
7513269 - 财政年份:2008
- 资助金额:
$ 53.89万 - 项目类别:
Split Proteins As Boolean Circuits and Drugs of a New Kind
将蛋白质拆分为布尔电路和新型药物
- 批准号:
8118431 - 财政年份:2008
- 资助金额:
$ 53.89万 - 项目类别:
Split Proteins As Boolean Circuits and Drugs of a New Kind
将蛋白质拆分为布尔电路和新型药物
- 批准号:
7661504 - 财政年份:2008
- 资助金额:
$ 53.89万 - 项目类别:
Split Proteins As Boolean Circuits and Drugs of a New Kind
将蛋白质拆分为布尔电路和新型药物
- 批准号:
7871450 - 财政年份:2008
- 资助金额:
$ 53.89万 - 项目类别:
MULTITARGET DRUGS: VERIFICATION-OF-PRINCIPLE STUDIES
多靶点药物:原理验证研究
- 批准号:
6033211 - 财政年份:2000
- 资助金额:
$ 53.89万 - 项目类别:
MULTITARGET DRUGS: VERIFICATION-OF-PRINCIPLE STUDIES
多靶点药物:原理验证研究
- 批准号:
6342202 - 财政年份:2000
- 资助金额:
$ 53.89万 - 项目类别:
The GID Ubiquitin Ligase and the Pro/N-End Rule Pathway in Yeast and Mammals
酵母和哺乳动物中的 GID 泛素连接酶和 Pro/N 端规则通路
- 批准号:
10202561 - 财政年份:1995
- 资助金额:
$ 53.89万 - 项目类别:
MECHANICS AND FUNCTIONS OF THE N-END RULE PATHWAY
N 端规则路径的机制和功能
- 批准号:
7007642 - 财政年份:1995
- 资助金额:
$ 53.89万 - 项目类别:
Ubiquitin Ligases, Mechanisms and Functions of the N-End Rule Pathway
N 端规则通路的泛素连接、机制和功能
- 批准号:
7777747 - 财政年份:1995
- 资助金额:
$ 53.89万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 53.89万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 53.89万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 53.89万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 53.89万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 53.89万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 53.89万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 53.89万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 53.89万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 53.89万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 53.89万 - 项目类别:
Research Grant














{{item.name}}会员




